Beacon Hospital is a privately owned full-service teaching hospital located in the Sandyford suburb of Dublin, Ireland. The hospital was developed by Beacon Medical Group.

During the past decade, Beacon Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Hospital" #1 sponsor was "Cancer Trials Ireland" with 7 trials, followed by "University of Sydney" with 2 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Hospital" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "ANZICS Clinical Trials Group" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Hospital" are "Prostate Cancer" (3 trials), "Prostatic Neoplasms" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Breast Cancer" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Beacon Hospital" in a lesser frequency.

Most popular intervention types in "Beacon Hospital" are "Other" (5 trials), "Drug" (3 trials), "Radiation" (3 trials), "Behavioral" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Non-interventional" (2 trials), "Biomarker Analysis" (1 trials), "Concurrent chemoradiotherapy (cCRT)" (1 trials) and "Conventional NSAA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Hospital" are 7 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beacon Hospital". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Beacon Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".